Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

TMR During Coronary Bypass: CMS Convenes MCAC To Reconsider Coverage

This article was originally published in The Gray Sheet

Executive Summary

CMS should gather more prospective clinical trial data on transmyocardial revascularization during cardiac bypass surgery (TMR + CABG) before considering changes to its TMR Medicare coverage policy, the Society of Thoracic Surgery argues

You may also be interested in...



AHRQ Tech Appraisal, Blues’ TEC Reveal Reservations With TMR Clinical Data

The Blues' Technology Evaluation Center shares CMS' apparent dissatisfaction with existing clinical evidence for transmyocardial revascularization (TMR) performed with coronary artery bypass surgery

AHRQ Tech Appraisal, Blues’ TEC Reveal Reservations With TMR Clinical Data

The Blues' Technology Evaluation Center shares CMS' apparent dissatisfaction with existing clinical evidence for transmyocardial revascularization (TMR) performed with coronary artery bypass surgery

TMR Endorsed For Some Ischemia Patients By Society Of Thoracic Surgeons

Society of Thoracic Surgeons evidence-based 1guidelines on transmyocardial laser revascularization (TMR), released March 30, are the first clinical practice guidelines to be issued by the organization

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020447

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel